$3.92
-15.58-79.9%
Last update: Oct 2, 3:58 PM
INTERPACE BIOSCIENCES NEW by Interpace Biosciences, Inc.
IDXGOTCID
INTERPACE BIOSCIENCES NEW by Interpace Biosciences, Inc. (IDXG) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
INTERPACE BIOSCIENCES NEW by Interpace Biosciences, Inc. (IDXG) last issued guidance on January 20, 2026 for fiscal year 2026. The company guided revenue in the range of $40M - $40M for the period.
Compared to prior guidance, INTERPACE BIOSCIENCES NEW by Interpace Biosciences, Inc. raised its revenue forecast from a prior range of $38M - $39M.
INTERPACE BIOSCIENCES NEW by Interpace Biosciences, Inc. has issued 2 guidance updates between January 20, 2026 and January 20, 2026. During this period, the company raised its outlook 1 time, reflecting management's growing confidence in business performance.
| Metric | Q3 '21 |
|---|---|
| Earnings Per Share (Non-GAAP) | |
| Estimate | — |
| Actual | $-0.84 |
| Surprise | — |
| Revenue | |
| Estimate | — |
| Actual | $9.5M |
| Surprise | — |
